Marco Danova
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Neutropenia and Cancer Infections, Cancer Genomics and Diagnostics, Acute Myeloid Leukemia Research, Colorectal Cancer Treatments and Studies
Most-Cited Works
- Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.(1988)
- → Objective Response to Chemotherapy As a Potential Surrogate End Point of Survival in Metastatic Breast Cancer Patients(2005)124 cited
- → Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients(2010)107 cited
- → Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study(2009)99 cited
- → All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells(1998)92 cited
- → Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial(2013)91 cited
- → Saporin, a ribosome‐inactivating protein used to prepare immunotoxins, induces cell death via apoptosis(1996)90 cited
- → Dendritic Cells and Vascular Endothelial Growth Factor in Colorectal Cancer: Correlations with Clinicobiological Findings(2005)89 cited
- → Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer(2010)88 cited
- Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.(1993)